| 000 | 01828 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518014339.0 | ||
| 264 | 0 | _c20190604 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1872-6844 | ||
| 024 | 7 |
_a10.1016/j.eplepsyres.2018.12.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aŞahin, Sevim | |
| 245 | 0 | 0 |
_aVitamin D protects against hippocampal apoptosis related with seizures induced by kainic acid and pentylenetetrazol in rats. _h[electronic resource] |
| 260 |
_bEpilepsy research _c01 2019 |
||
| 300 |
_a107-116 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xmetabolism |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aConvulsants _xtoxicity |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHippocampus _xpathology |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 |
_aKainic Acid _xtoxicity |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPentylenetetrazole _xtoxicity |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSeizures _xchemically induced |
| 650 | 0 | 4 |
_aVitamin D _xtherapeutic use |
| 650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
| 700 | 1 | _aGürgen, Seren Gülşen | |
| 700 | 1 | _aYazar, Uğur | |
| 700 | 1 | _aİnce, İmran | |
| 700 | 1 | _aKamaşak, Tülay | |
| 700 | 1 | _aAcar Arslan, Elif | |
| 700 | 1 | _aDiler Durgut, Betül | |
| 700 | 1 | _aDilber, Beril | |
| 700 | 1 | _aCansu, Ali | |
| 773 | 0 |
_tEpilepsy research _gvol. 149 _gp. 107-116 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eplepsyres.2018.12.005 _zAvailable from publisher's website |
| 999 |
_c29197327 _d29197327 |
||